See more : Innospec Inc. (IOSP) Income Statement Analysis – Financial Results
Complete financial analysis of Charles & Colvard, Ltd. (CTHR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Charles & Colvard, Ltd., a leading company in the Luxury Goods industry within the Consumer Cyclical sector.
You may be interested
- TOR Minerals International, Inc. (TORM) Income Statement Analysis – Financial Results
- BOCOM Schroders CSI OS China(QDII-LOF)A (164906.SZ) Income Statement Analysis – Financial Results
- Poniard Pharmaceuticals, Inc. PFD CV$2.4375 (PARDP) Income Statement Analysis – Financial Results
- Türkiye Sinai Kalkinma Bankasi A.S. (TRKYY) Income Statement Analysis – Financial Results
- San Far Property Limited (9946.TW) Income Statement Analysis – Financial Results
Charles & Colvard, Ltd. (CTHR)
About Charles & Colvard, Ltd.
Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. It also markets and distributes lab grown diamonds, and finished jewelry with lab grown diamonds under the Caydia brand. The company sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com, third-party online marketplaces, drop-ship, and other e-commerce outlets. Charles & Colvard, Ltd. was founded in 1995 and is headquartered in Morrisville, North Carolina.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 29.95M | 43.09M | 39.24M | 29.19M | 32.24M | 27.03M | 29.17M | 30.77M | 25.64M | 28.49M | 22.41M | 16.03M | 12.69M | 8.31M | 14.73M | 27.82M | 40.71M | 43.54M | 23.92M | 17.24M | 16.51M | 11.51M | 12.80M | 12.30M | 4.00M | 100.00K | 100.00K |
| Cost of Revenue | 25.21M | 22.85M | 20.81M | 21.20M | 17.35M | 15.47M | 20.40M | 20.55M | 18.01M | 14.60M | 9.96M | 6.51M | 4.83M | 3.47M | 5.59M | 7.61M | 10.80M | 14.46M | 8.57M | 6.58M | 6.59M | 5.14M | 5.26M | 5.70M | 2.70M | 0.00 | 0.00 |
| Gross Profit | 4.73M | 20.24M | 18.43M | 7.99M | 14.89M | 11.56M | 8.77M | 10.21M | 7.63M | 13.89M | 12.45M | 9.52M | 7.86M | 4.84M | 9.13M | 20.21M | 29.92M | 29.08M | 15.35M | 10.66M | 9.93M | 6.37M | 7.54M | 6.60M | 1.30M | 100.00K | 100.00K |
| Gross Profit Ratio | 15.81% | 46.98% | 46.96% | 27.37% | 46.19% | 42.77% | 30.06% | 33.20% | 29.75% | 48.75% | 55.56% | 59.39% | 61.96% | 58.22% | 62.02% | 72.65% | 73.48% | 66.78% | 64.17% | 61.86% | 60.11% | 55.34% | 58.90% | 53.66% | 32.50% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 2.07K | 3.71K | 2.85K | 17.80K | 18.07K | 24.90K | 17.01K | 145.72K | 99.89K | 401.50K | 113.62K | 76.65K | 73.23K | 215.78K | 14.08K | 26.70K | 7.26K | 21.98K | 1.44M | 2.70M | 4.00M | 2.10M | 200.00K |
| General & Administrative | 5.02M | 4.95M | 4.44M | 4.86M | 4.64M | 4.69M | 5.54M | 7.38M | 6.79M | 5.48M | 4.76M | 4.67M | 4.53M | 5.70M | 15.92M | 19.81M | 20.41M | 19.74M | 12.29M | 8.54M | 7.37M | 5.33M | 12.72M | 9.40M | 5.70M | 3.30M | 200.00K |
| Selling & Marketing | 13.69M | 12.42M | 8.48M | 9.44M | 7.98M | 7.48M | 7.04M | 12.36M | 9.85M | 9.87M | 7.44M | 3.31M | 1.99M | 1.95M | 7.47M | 14.09M | 16.11M | 15.57M | 9.29M | 6.08M | 4.97M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 18.71M | 17.37M | 12.92M | 14.30M | 12.62M | 12.17M | 12.58M | 19.75M | 16.64M | 15.34M | 12.20M | 7.98M | 6.52M | 7.65M | 15.92M | 19.81M | 20.41M | 19.74M | 12.29M | 8.54M | 7.37M | 5.33M | 12.72M | 9.40M | 5.70M | 3.30M | 200.00K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -13.00 | 0.00 | 20.40M | 0.00 | 0.00 | 0.00 | 0.00 | 94.41K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -450.00 | 119.46K | 569.99K | 700.00K | 200.00K | 0.00 | 0.00 |
| Operating Expenses | 18.71M | 17.37M | 12.92M | 14.30M | 12.63M | 12.17M | 12.59M | 19.76M | 16.66M | 15.37M | 12.22M | 8.22M | 6.62M | 8.05M | 16.03M | 19.88M | 20.49M | 19.95M | 12.31M | 8.57M | 7.38M | 5.47M | 14.73M | 12.80M | 9.90M | 5.40M | 400.00K |
| Cost & Expenses | 43.92M | 40.22M | 33.73M | 35.50M | 29.98M | 27.64M | 32.99M | 40.32M | 34.67M | 29.97M | 22.18M | 14.73M | 11.44M | 11.53M | 21.63M | 27.49M | 31.28M | 34.41M | 20.88M | 15.15M | 13.96M | 10.61M | 19.99M | 18.50M | 12.60M | 5.40M | 400.00K |
| Interest Income | 297.26K | 19.28K | 5.58K | 158.09K | 11.02K | 0.00 | 0.00 | 11.00 | 65.00 | 22.01K | 69.52K | 85.27K | 109.18K | 38.19K | 116.48K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 19.28K | 8.95K | 884.00 | 2.20K | 541.00 | 1.74K | 10.36K | 901.00 | 2.11K | 1.26K | 1.14K | 2.83K | 107.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.22M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 653.16K | 479.31K | 567.12K | 490.24K | 481.32K | 422.02K | 557.39K | 863.35K | 1.11M | 862.68K | 608.17K | 299.55K | 136.62K | 168.88K | 216.03K | 200.63K | 188.76K | 247.44K | 197.19K | 161.90K | 128.60K | 150.94K | 569.99K | 700.00K | 200.00K | 400.00K | -100.00K |
| EBITDA | -13.03M | 3.35M | 6.23M | -5.67M | 3.14M | -3.85K | -3.38M | -4.32M | -7.94M | -697.70K | 936.01K | 1.68M | 1.46M | -3.36M | -6.57M | 526.07K | 9.62M | 9.38M | 3.24M | 2.09M | 2.55M | 1.05M | -6.62M | -5.50M | -8.40M | -5.30M | -300.00K |
| EBITDA Ratio | -43.50% | 7.83% | 15.50% | -19.42% | 8.55% | -0.69% | -11.18% | -28.23% | -30.91% | -2.10% | 4.08% | 10.51% | 11.73% | -34.88% | -45.39% | 1.89% | 23.62% | 21.54% | 13.53% | 13.09% | 16.23% | 10.17% | -49.31% | -44.72% | -255.00% | -5,800.00% | -300.00% |
| Operating Income | -13.98M | 2.87M | 5.51M | -6.32M | 2.27M | -608.54K | -3.94M | -9.55M | -9.04M | -1.58M | 234.07K | 1.30M | 1.24M | -3.36M | -6.90M | 325.45K | 9.43M | 9.13M | 3.04M | 2.09M | 2.55M | 899.14K | -7.19M | -6.20M | -8.60M | -5.30M | -300.00K |
| Operating Income Ratio | -46.67% | 6.67% | 14.04% | -21.64% | 7.03% | -2.25% | -13.50% | -31.04% | -35.27% | -5.55% | 1.04% | 8.10% | 9.79% | -40.42% | -46.85% | 1.17% | 23.16% | 20.97% | 12.70% | 12.15% | 15.45% | 7.82% | -56.22% | -50.41% | -215.00% | -5,300.00% | -300.00% |
| Total Other Income/Expenses | 297.26K | 19.24K | 970.35K | 155.38K | 8.47K | 182.68K | -1.74K | -10.22K | -836.00 | 19.90K | 68.26K | 84.85K | 80.82K | 38.19K | 116.48K | 491.14K | 741.16K | 503.76K | 138.22K | 112.36K | 199.08K | 325.60K | 114.54K | 1.00M | 1.80M | 500.00K | -100.00K |
| Income Before Tax | -13.68M | 2.89M | 6.48M | -6.16M | 2.27M | -425.87K | -3.94M | -9.56M | -9.05M | -1.56M | 302.33K | 1.38M | 1.32M | -3.32M | -6.78M | 816.58K | 10.17M | 9.63M | 3.18M | 2.21M | 2.75M | 1.22M | -7.08M | -5.20M | -6.70M | -4.90M | -400.00K |
| Income Before Tax Ratio | -45.68% | 6.71% | 16.51% | -21.11% | 7.05% | -1.58% | -13.50% | -31.07% | -35.28% | -5.48% | 1.35% | 8.63% | 10.43% | -39.96% | -46.06% | 2.94% | 24.98% | 22.12% | 13.28% | 12.80% | 16.66% | 10.65% | -55.32% | -42.28% | -167.50% | -4,900.00% | -400.00% |
| Income Tax Expense | 5.90M | 518.53K | -6.33M | 1.73K | -1.44K | 27.61K | 13.48K | 12.82K | 4.05M | -269.29K | -4.15M | -183.95K | -234.28K | 77.71K | -632.67K | 841.01K | 4.07M | 3.76M | 1.56M | 1.16M | -6.66M | -1.22M | 7.08M | 5.20M | 6.70M | 4.90M | 400.00K |
| Net Income | -19.58M | 2.37M | 12.81M | -6.16M | 2.28M | -453.48K | -4.53M | -9.57M | -13.10M | -1.29M | 4.45M | 1.57M | 1.56M | -3.40M | -6.15M | -24.42K | 6.11M | 5.87M | 1.61M | 1.04M | 9.41M | 1.22M | -7.08M | -5.20M | -6.70M | -4.90M | -400.00K |
| Net Income Ratio | -65.39% | 5.51% | 32.65% | -21.11% | 7.06% | -1.68% | -15.52% | -31.11% | -51.08% | -4.53% | 19.85% | 9.78% | 12.27% | -40.89% | -41.77% | -0.09% | 15.00% | 13.49% | 6.74% | 6.05% | 56.97% | 10.65% | -55.32% | -42.28% | -167.50% | -4,900.00% | -400.00% |
| EPS | -0.64 | 0.08 | 0.44 | -0.22 | 0.10 | -0.02 | -0.22 | -0.47 | -0.65 | -0.06 | 0.23 | 0.08 | 0.08 | -0.18 | -0.34 | 0.00 | 0.34 | 0.33 | 0.09 | 0.06 | 0.53 | 0.08 | -0.75 | -0.56 | -0.73 | -1.31 | -0.15 |
| EPS Diluted | -0.64 | 0.08 | 0.42 | -0.22 | 0.10 | -0.02 | -0.22 | -0.47 | -0.65 | -0.06 | 0.22 | 0.08 | 0.08 | -0.18 | -0.34 | 0.00 | 0.33 | 0.31 | 0.09 | 0.06 | 0.53 | 0.08 | -0.75 | -0.56 | -0.73 | -1.31 | -0.15 |
| Weighted Avg Shares Out | 30.38M | 30.36M | 29.14M | 28.64M | 21.86M | 21.19M | 20.80M | 20.35M | 20.15M | 19.90M | 19.58M | 19.44M | 19.18M | 18.72M | 18.24M | 18.07M | 18.16M | 18.01M | 17.47M | 17.36M | 17.53M | 16.47M | 9.41M | 9.24M | 9.13M | 3.74M | 2.67M |
| Weighted Avg Shares Out (Dil) | 30.38M | 31.32M | 30.23M | 28.64M | 22.11M | 21.19M | 20.93M | 20.41M | 20.30M | 19.90M | 19.97M | 19.70M | 19.42M | 18.72M | 18.24M | 18.07M | 18.66M | 18.96M | 18.01M | 17.78M | 17.91M | 16.48M | 9.41M | 9.24M | 9.13M | 3.74M | 2.67M |
CHARLES & COLVARD REPORTS FIRST QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS
$7.4 Million in Net Sales $16.6 Million Total Cash as of September 30, 2022 85% Increase in Lab Grown Diamond Sales and 12% Decrease in Moissanite Sales on charlesandcolvard.com Versus the Year Ago Quarter Opened First Retail Signature Showroom Location...
CHARLES & COLVARD TO HOST ITS FIRST QUARTER FISCAL YEAR 2023 INVESTOR CONFERENCE CALL ON NOVEMBER 3, 2022 AT 4:30 PM ET
RESEARCH TRIANGLE PARK, N.C. , Oct. 20, 2022 /PRNewswire/ -- Charles & Colvard, Ltd.
Charles & Colvard to Open First Brick & Mortar Signature Showroom in Morrisville, NC
RESEARCH TRIANGLE PARK, N.C., Oct. 13, 2022 /PRNewswire/ — Charles & Colvard, Ltd. (Nasdaq: CTHR) (the “Company”), a globally recognized fine jewelry company specializing in lab grown gemstones, today announced the scheduled opening of a brick-and-mortar showroom for customers to...
Charles & Colvard to Open First Brick & Mortar Signature Showroom in Morrisville, NC
RESEARCH TRIANGLE PARK, N.C. , Oct. 13, 2022 /PRNewswire/ -- Charles & Colvard, Ltd.
Charles & Colvard® Launches Lab Grown Precious Gemstones Giving Their Conscious Fine Jewelry Bold New Color
RESEARCH TRIANGLE PARK, N.C. , Oct. 6, 2022 /PRNewswire/ -- Charles & Colvard, Ltd.
Hey Contrarian Investors! 7 Stocks to Buy Before Inflation Falls.
With the world's most powerful central bank committed to tackling soaring prices, it may be time for investors to consider specific stocks to buy for falling inflation. Here's the reason why forward-looking market participants anticipate lower prices over the next...
Charles & Colvard® Expands Signature Collection to Include All New Lab Grown Diamond Men's Bands
RESEARCH TRIANGLE PARK, N.C. , Sept. 15, 2022 /PRNewswire/ -- Charles & Colvard, Ltd.
Charles & Colvard, Ltd. (CTHR) Q4 2022 Earnings Call Transcript
Charles & Colvard, Ltd. (NASDAQ:CTHR ) Q4 2022 Earnings Conference Call September 1, 2022 4:30 PM ET Company Participants Don O'Connell - President and Chief Executive Officer Clint Pete - Chief Financial Officer Conference Call Participants Operator Hello and welcome...
Charles & Colvard Ltd (CTHR) Reports Break-Even Earnings for Q4
Charles & Colvard Ltd (CTHR) delivered earnings and revenue surprises of 100% and 17.77%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
CHARLES & COLVARD REPORTS FOURTH QUARTER AND FULL FISCAL YEAR 2022 FINANCIAL RESULTS
Generated $9.3 Million in Net Sales for Q4 of Fiscal 2022 Delivered All-Time High for the Company of $43.1 Million in Net Sales for Fiscal 2022 Experienced 173% Increase in Lab Grown Diamond Sales and 13% Increase in Moissanite Sales...
Source: https://incomestatements.info
Category: Stock Reports